BIOMAT Database Logo BIOMAT Database Logo

[The actual aspects of measles vaccinations (author's transl)]. 1979

A Falorni, and F Passalacqua

Following a brief introduction to measles epidemiological aspects and complications, the Authors expound on the essential characteristics of various types of vaccinations. They then synthesize the effects, indications, contraindications and duration of the immunization in relation to measles vaccinations.

UI MeSH Term Description Entries
D008457 Measles A highly contagious infectious disease caused by MORBILLIVIRUS, common among children but also seen in the nonimmune of any age, in which the virus enters the respiratory tract via droplet nuclei and multiplies in the epithelial cells, spreading throughout the MONONUCLEAR PHAGOCYTE SYSTEM. Rubeola
D008458 Measles Vaccine A live attenuated virus vaccine of chick embryo origin, used for routine immunization of children and for immunization of adolescents and adults who have not had measles or been immunized with live measles vaccine and have no serum antibodies against measles. Children are usually immunized with measles-mumps-rubella combination vaccine. (From Dorland, 28th ed) Vaccine, Measles
D008459 Measles virus The type species of MORBILLIVIRUS and the cause of the highly infectious human disease MEASLES, which affects mostly children. Edmonston virus
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000914 Antibodies, Viral Immunoglobulins produced in response to VIRAL ANTIGENS. Viral Antibodies
D014611 Vaccination Administration of vaccines to stimulate the host's immune response. This includes any preparation intended for active immunological prophylaxis. Immunization, Active,Active Immunization,Active Immunizations,Immunizations, Active,Vaccinations
D014613 Vaccines, Attenuated Live vaccines prepared from microorganisms which have undergone physical adaptation (e.g., by radiation or temperature conditioning) or serial passage in laboratory animal hosts or infected tissue/cell cultures, in order to produce avirulent mutant strains capable of inducing protective immunity. Attenuated Vaccine,Vaccines, Live, Attenuated,Attenuated Vaccines,Vaccine, Attenuated

Related Publications

A Falorni, and F Passalacqua
[Actual aspects of primary hyperparathyroidism (author's transl)].
January 1974, Folia clinica internacional,
A Falorni, and F Passalacqua
[Actual aspects of the acute virus hepatitis (author's transl)].
August 1978, Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis,
A Falorni, and F Passalacqua
[Actual aspects of pulmonary treatment in cystic fibrosis (author's transl)].
June 1978, Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis,
A Falorni, and F Passalacqua
[Actual aspects of therapy with beta-adrenergic stimulants (author's transl)].
February 1981, Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis,
A Falorni, and F Passalacqua
[Measles pneumonia (author's transl)].
January 1980, Taiwan yi xue hui za zhi. Journal of the Formosan Medical Association,
A Falorni, and F Passalacqua
[Complications following vaccinations (report) (author's transl)].
January 1972, Verhandlungen der Deutschen Gesellschaft fur Pathologie,
A Falorni, and F Passalacqua
[Actual therapy of epilepsy (author's transl)].
February 1982, Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis,
A Falorni, and F Passalacqua
[Epidemiology of measles (author's transl)].
June 1979, Annali Sclavo; rivista di microbiologia e di immunologia,
A Falorni, and F Passalacqua
[Vaccinations therapy of laryngeal papillomatosis (author's transl)].
May 1980, Zeitschrift fur Erkrankungen der Atmungsorgane,
A Falorni, and F Passalacqua
[Wilms' tumors: the actual standpoint (author's transl)].
May 1981, Klinische Padiatrie,
Copied contents to your clipboard!